Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

NCT01953640 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Hormone-Resistant Prostate Cancer
Metastatic Prostate Carcinoma
Prostate Adenocarcinoma
Recurrent Prostate Carcinoma

Interventions

OTHER: Laboratory Biomarker Analysis
OTHER: Quality-of-Life Assessment

Sponsor

Mayo Clinic

Collaborators

[object Object]